Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 25:13:802292.
doi: 10.3389/fmicb.2022.802292. eCollection 2022.

Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting

Monica Irungbam  1 , Anubhuti Chitkara  1 , Vijay Kumar Singh  2 , Subash Chandra Sonkar  2 , Abhisek Dubey  1 , Aastha Bansal  1 , Ritika Shrivastava  1 , Binita Goswami  1   2 , Vikas Manchanda  3 , Sonal Saxena  3 , Ritu Saxena  4 , Sandeep Garg  5 , Farah Husain  6 , Tanmay Talukdar  7 , Dinesh Kumar  8 , Bidhan Chandra Koner  1   2
Affiliations

Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting

Monica Irungbam et al. Front Microbiol. .

Abstract

Background: Antibody testing is often used for serosurveillance of coronavirus disease 2019 (COVID-19). Enzyme-linked immunosorbent assay and chemiluminescence-based antibody tests are quite sensitive and specific for such serological testing. Rapid antibody tests against different antigens are developed and effectively used for this purpose. However, their diagnostic efficiency, especially in real-life hospital setting, needs to be evaluated. Thus, the present study was conducted in a dedicated COVID-19 hospital in New Delhi, India, to evaluate the diagnostic efficacy of a rapid antibody kit against the receptor-binding domain (RBD) of the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Methods: Sixty COVID-19 confirmed cases by reverse transcriptase-polymerase chain reaction (RT-PCR) were recruited and categorized as early, intermediate, and late cases based on the days passed after their first RT-PCR-positive test report, with 20 subjects in each category. Twenty samples from pre-COVID era and 20 RT-PCR-negative collected during the study period were taken as controls. immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against the RBD of the spike (S) protein of SARS-CoV-2 virus were detected by rapid antibody test and compared with the total antibody against the nucleocapsid (N) antigen of SARS-CoV-2 by electrochemiluminescence-based immunoassay (ECLIA).

Results: The detection of IgM against the RBD of the spike protein by rapid kit was less sensitive and less specific for the diagnosis of SARS-CoV-2 infection. However, diagnostic efficacy of IgG by rapid kit was highly sensitive and specific when compared with the total antibody against N antigen measured by ECLIA.

Conclusion: It can be concluded that detection of IgM against the RBD of S protein by rapid kit is less effective, but IgG detection can be used as an effective diagnostic tool for SARS-CoV-2 infection in real-life hospital setting.

Keywords: COVID-19; SARS-CoV-2; chemiluminescence analysis; rapid antibody tests for COVID-19; receptor-binding domain (RBD); spike surface glycoprotein.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Afzal A. (2020). Molecular diagnostic technologies for COVID-19: limitations and challenges. J. Adv. Res. 26 149–159. 10.1016/j.jare.2020.08.002 - DOI - PMC - PubMed
    1. Alsaud A. E., Nair A. P., Matarneh A. S., Sasi S., El Hassan R., Khan F., et al. (2021). Case report: prolonged viral shedding in six COVID-19 patients. Am. J. Trop. Med. Hyg. 104 1472–1475. 10.4269/ajtmh.20-0933 - DOI - PMC - PubMed
    1. Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. (2020). The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike–based vaccine immunogens. Front. Immunol. 11:576622. 10.3389/fimmu.2020.576622 - DOI - PMC - PubMed
    1. Dubey A., Bansal A., Sonkar S. C., Goswami B., Makwane N., Manchanda V., et al. (2020). In–house assembled protective devices in laboratory safety against SARS-nCoV-2 in clinical biochemistry laboratory of a COVID dedicated hospital. medRxiv [Preprint] medRxiv 2020 08.24.20155713 10.1101/2020.08.24.20155713 - DOI
    1. Dubey A., Kotnala G., Mandal T. K., Sonkar S. C., Singh V. K., Guru S. A., et al. (2021). Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital. J. Med. Virol. 93 5339–5349. 10.1002/jmv.27029 - DOI - PMC - PubMed